<code id='F106478379'></code><style id='F106478379'></style>
    • <acronym id='F106478379'></acronym>
      <center id='F106478379'><center id='F106478379'><tfoot id='F106478379'></tfoot></center><abbr id='F106478379'><dir id='F106478379'><tfoot id='F106478379'></tfoot><noframes id='F106478379'>

    • <optgroup id='F106478379'><strike id='F106478379'><sup id='F106478379'></sup></strike><code id='F106478379'></code></optgroup>
        1. <b id='F106478379'><label id='F106478379'><select id='F106478379'><dt id='F106478379'><span id='F106478379'></span></dt></select></label></b><u id='F106478379'></u>
          <i id='F106478379'><strike id='F106478379'><tt id='F106478379'><pre id='F106478379'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:2
          Adobe

          Hospitals and medical groups say they’re still reeling from the effects of the cyberattack on a UnitedHealth Group subsidiary, but the massive company at the center of the debacle has so far emerged largely unscathed, with executives on Tuesday praising its strength and resilience.

          The almost $8 billion UnitedHealth made on operations in the first three months of 2024 was roughly the same as the prior-year period. Despite the Change Healthcare cyberattack, the health insurance, provider, and technology conglomerate reaffirmed its adjusted earnings outlook for the year, and its share price grew more than 5% by market close.

          advertisement

          Ultimately, UnitedHealth said it’ll take an up to $1.6 billion hit from the cyberattack this year, a drop in the bucket for a company that’s expected to generate $400 billion in revenue.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          UnitedHealth starts bidding war with $3.3 billion offer for Amedisys
          UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

          UnitedHealthGroupisattemptingtobuyAmedisysfor$3.3billion.CourtesyUnitedHealthGroupThere’snowatwo-par

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

          8:47PresidentJoeBidenspeaksabouttheSupremeCourt'sdecisiontostrikedownrace-consciousstudentadmissions